Robert Nechanitzky is currently working as a Scientific Lead in Research at Providence Therapeutics. Prior to this, Robert held the title of Scientist II in Immune-Oncology at the same company. Robert also has experience as a Scientific Associate at University Health Network and as a Postdoc at Max Planck Institute of Immunobiology and Epigenetics. Robert holds a PhD in Immunology from The University of Freiburg.
February 1, 2024 - present
February, 2023